Semi-quantitative detection of 33 psychoactive substances from DBS by LC-MS/MS. Screening-level substance detection on a graded scale.
This panel provides semi-quantitative detection of 33 psychoactive substances from a dried blood spot, reported on a graded scale (+/++/+++). Designed for informational screening purposes.
Clinical indications include:
33 substances including amphetamines, benzodiazepines, opioids (morphine, codeine, fentanyl), cocaine and metabolites, MDMA, tramadol, methadone, buprenorphine, and synthetic cannabinoids. Results reported on semi-quantitative +/++/+++ scale.
All 33 substances are detected simultaneously by LC-MS/MS from a single DBS sample. The semi-quantitative grading system provides indication of exposure level without formal forensic quantification.
Psychoactive Substances is an important biomarker for workplace substance screening from dbs. Masdiag measures psychoactive substances using validated analytical methods to provide clinically actionable results.
Psychoactive Substances testing is valuable for Workplace substance screening from DBS, Monitoring of substance use in therapeutic settings. Understanding psychoactive substances levels helps inform personalized health optimization and clinical decision-making.
Psychoactive Substances collection is simple and convenient: prick your finger at home to collect a dried blood spot (DBS). This allows remote sampling without venepuncture.
This test is recommended for individuals interested in workplace substance screening from dbs. Masdiag psychoactive substances testing helps guide personalized supplementation and health optimization strategies based on objective biomarker data.
Psychoactive Substances results provide insight into your metabolic status and workplace substance screening from dbs. Combined with clinical context, Masdiag results inform evidence-based interventions for personalized health optimization.
Whether you need testing services, method transfer, or white-label kit development — we'd love to hear from you.